Human Gene MIR101-1 (uc001dbx.3) Description and Page Index
  Description: Homo sapiens microRNA 101-1 (MIR101-1), microRNA.
RefSeq Summary (NR_029516): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: AF480539.1, LM608189.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr1:65,524,117-65,524,191 Size: 75 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksRNA-Seq ExpressionMicroarray ExpressionOther SpeciesmRNA Descriptions
Other NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:65,524,117-65,524,191)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerHGNCLynxOMIMPubMed
Stanford SOURCE

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  FU261130 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763632 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304531 - JP 2009531018-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305029 - JP 2009531019-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119238 - JP 2013046612-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589567 - JP 2013121348-A/98: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413371 - JP 2014060993-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501582 - JP 2016025853-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA525948 - Sequence 98 from Patent EP2369011.
JA526455 - Sequence 98 from Patent EP2369012.
JA526962 - Sequence 98 from Patent EP2369013.
JA535891 - Sequence 98 from Patent EP2371971.
JA787896 - Sequence 98 from Patent EP2479285.
JA788394 - Sequence 98 from Patent EP2479286.
JA810728 - Sequence 98 from Patent EP2468890.
JA811226 - Sequence 98 from Patent EP2468891.
JA811724 - Sequence 98 from Patent EP2468893.
JA812222 - Sequence 98 from Patent EP2468894.
JA812720 - Sequence 98 from Patent EP2468895.
JA813218 - Sequence 98 from Patent EP2468896.
JA813716 - Sequence 98 from Patent EP2468897.
JA814214 - Sequence 98 from Patent EP2468898.
JA814712 - Sequence 98 from Patent EP2468899.
JA816955 - Sequence 98 from Patent EP2468892.
JA825767 - Sequence 98 from Patent EP2471956.
JA826265 - Sequence 98 from Patent EP2471958.
JB024552 - Sequence 98 from Patent EP2505668.
JB025050 - Sequence 98 from Patent EP2505669.
JB079437 - Sequence 98 from Patent EP2487252.
JB079935 - Sequence 98 from Patent EP2487253.
JB080433 - Sequence 98 from Patent EP2487254.
JB080931 - Sequence 98 from Patent EP2487255.
JB081429 - Sequence 98 from Patent EP2487256.
JB081927 - Sequence 98 from Patent EP2487257.
JB082425 - Sequence 98 from Patent EP2487258.
JB082923 - Sequence 98 from Patent EP2487259.
JB083421 - Sequence 98 from Patent EP2487260.
JB083919 - Sequence 98 from Patent EP2487261.
JB084417 - Sequence 98 from Patent EP2487262.
JB084915 - Sequence 98 from Patent EP2487263.
JB087593 - Sequence 98 from Patent EP2502630.
JB147797 - Sequence 98 from Patent EP2484782.
JB148295 - Sequence 98 from Patent EP2484783.
JB153020 - Sequence 98 from Patent EP2514433.
JB153518 - Sequence 98 from Patent EP2514434.
JB622107 - Sequence 98 from Patent EP2586454.
JB622605 - Sequence 98 from Patent EP2586455.
JC001668 - Sequence 98 from Patent EP2591794.
AF480539 - Homo sapiens miR-101-precursor-1 micro RNA, complete sequence.
CS266378 - Sequence 70 from Patent WO2005118806.
DI443403 - KR 1020140074997-A/24: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DL076540 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004190 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261132 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763634 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421532 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304533 - JP 2009531018-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305031 - JP 2009531019-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119240 - JP 2013046612-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367403 - JP 2012228254-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411796 - JP 2014000079-A/70: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505203 - JP 2014502606-A/105: MELANOMA TREATMENTS.
HW589569 - JP 2013121348-A/100: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674142 - JP 2014217381-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW807729 - JP 2014534810-A/24: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ043284 - JP 2015510401-A/374: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067084 - JP 2014012020-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081910 - JP 2015514392-A/374: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408246 - JP 2015528002-A/843: CHIRAL CONTROL.
HZ413373 - JP 2014060993-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427508 - JP 2014217384-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428311 - JP 2014217385-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429114 - JP 2014217386-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429917 - JP 2014217387-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501584 - JP 2016025853-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769174 - JP 2014223080-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058568 - Sequence 70 from Patent EP2298893.
JA059371 - Sequence 70 from Patent EP2298894.
JA073694 - Sequence 70 from Patent EP2281887.
JA104831 - Sequence 70 from Patent EP2302051.
JA106171 - Sequence 70 from Patent EP2302052.
JA106974 - Sequence 70 from Patent EP2302053.
JA107777 - Sequence 70 from Patent EP2302054.
JA108580 - Sequence 70 from Patent EP2302055.
JA109383 - Sequence 70 from Patent EP2302056.
JA191899 - Sequence 70 from Patent EP2290066.
JA192798 - Sequence 70 from Patent EP2290067.
JA193697 - Sequence 70 from Patent EP2290068.
JA194596 - Sequence 70 from Patent EP2290069.
JA195495 - Sequence 70 from Patent EP2290070.
JA196394 - Sequence 70 from Patent EP2290071.
JA197293 - Sequence 70 from Patent EP2290072.
JA198192 - Sequence 70 from Patent EP2290073.
JA199091 - Sequence 70 from Patent EP2290074.
JA199990 - Sequence 70 from Patent EP2290075.
JA200889 - Sequence 70 from Patent EP2290076.
JA218011 - Sequence 70 from Patent EP2281888.
JA226162 - Sequence 70 from Patent EP2292755.
JA229017 - Sequence 70 from Patent EP2292756.
JA257288 - Sequence 70 from Patent EP2284265.
JA278568 - Sequence 70 from Patent EP2281886.
JA284454 - Sequence 70 from Patent EP2281889.
JA292507 - Sequence 70 from Patent EP2287303.
JA317693 - Sequence 70 from Patent EP2314688.
JA374752 - Sequence 70 from Patent EP2322616.
JA525950 - Sequence 100 from Patent EP2369011.
JA526457 - Sequence 100 from Patent EP2369012.
JA526964 - Sequence 100 from Patent EP2369013.
JA535893 - Sequence 100 from Patent EP2371971.
JA787898 - Sequence 100 from Patent EP2479285.
JA788396 - Sequence 100 from Patent EP2479286.
JA810730 - Sequence 100 from Patent EP2468890.
JA811228 - Sequence 100 from Patent EP2468891.
JA811726 - Sequence 100 from Patent EP2468893.
JA812224 - Sequence 100 from Patent EP2468894.
JA812722 - Sequence 100 from Patent EP2468895.
JA813220 - Sequence 100 from Patent EP2468896.
JA813718 - Sequence 100 from Patent EP2468897.
JA814216 - Sequence 100 from Patent EP2468898.
JA814714 - Sequence 100 from Patent EP2468899.
JA816957 - Sequence 100 from Patent EP2468892.
JA825769 - Sequence 100 from Patent EP2471956.
JA826267 - Sequence 100 from Patent EP2471958.
JB024554 - Sequence 100 from Patent EP2505668.
JB025052 - Sequence 100 from Patent EP2505669.
JB037931 - Sequence 47 from Patent WO2012107841.
JB079439 - Sequence 100 from Patent EP2487252.
JB079937 - Sequence 100 from Patent EP2487253.
JB080435 - Sequence 100 from Patent EP2487254.
JB080933 - Sequence 100 from Patent EP2487255.
JB081431 - Sequence 100 from Patent EP2487256.
JB081929 - Sequence 100 from Patent EP2487257.
JB082427 - Sequence 100 from Patent EP2487258.
JB082925 - Sequence 100 from Patent EP2487259.
JB083423 - Sequence 100 from Patent EP2487260.
JB083921 - Sequence 100 from Patent EP2487261.
JB084419 - Sequence 100 from Patent EP2487262.
JB084917 - Sequence 100 from Patent EP2487263.
JB087595 - Sequence 100 from Patent EP2502630.
JB147799 - Sequence 100 from Patent EP2484782.
JB148297 - Sequence 100 from Patent EP2484783.
JB153022 - Sequence 100 from Patent EP2514433.
JB153520 - Sequence 100 from Patent EP2514434.
JB622109 - Sequence 100 from Patent EP2586454.
JB622607 - Sequence 100 from Patent EP2586455.
JC001670 - Sequence 100 from Patent EP2591794.
JC221595 - Sequence 70 from Patent EP2471923.
JC268161 - Sequence 70 from Patent EP2471924.
JC340469 - Sequence 70 from Patent EP2471922.
JC469715 - Sequence 70 from Patent EP2471921.
JC526213 - Sequence 3 from Patent WO2014083081.
JC990504 - Sequence 70 from Patent EP2808390.
LF404381 - JP 2015509366-A/374: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714607 - JP 2016165292-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856541 - JP 2015142597-A/70: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051580 - KR 1020150036642-A/846: CHIRAL CONTROL.
LQ101342 - Sequence 47 from Patent WO2015101653.
LQ276057 - Sequence 47 from Patent WO2016071729.
MA259150 - JP 2017502699-A/47: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA353912 - JP 2018075017-A/374: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
AF480499 - Homo sapiens microRNA miR-101 gene, complete sequence.
CS166338 - Sequence 49 from Patent WO2005078096.
CS265311 - Sequence 53 from Patent EP1627925.
CS444366 - Sequence 53 from Patent WO2006108473.
CS548248 - Sequence 1278 from Patent EP1777301.
DJ003739 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027018 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DL231883 - Method for the determination of cellular transcriptional regulation.
FU261398 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU261399 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763900 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FU763901 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW311989 - DETECTING NUCLEIC ACIDS.
HV304799 - JP 2009531018-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304800 - JP 2009531018-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305297 - JP 2009531019-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV305298 - JP 2009531019-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954032 - JP 2012518421-A/944: METHODS OF DETECTING LUNG CANCER.
HW119506 - JP 2013046612-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119507 - JP 2013046612-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589835 - JP 2013121348-A/366: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW589836 - JP 2013121348-A/367: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413639 - JP 2014060993-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ413640 - JP 2014060993-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501850 - JP 2016025853-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501851 - JP 2016025853-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526216 - Sequence 366 from Patent EP2369011.
JA526217 - Sequence 367 from Patent EP2369011.
JA526723 - Sequence 366 from Patent EP2369012.
JA526724 - Sequence 367 from Patent EP2369012.
JA527230 - Sequence 366 from Patent EP2369013.
JA527231 - Sequence 367 from Patent EP2369013.
JA536159 - Sequence 366 from Patent EP2371971.
JA536160 - Sequence 367 from Patent EP2371971.
JA715162 - Sequence 944 from Patent EP2401406.
JA788164 - Sequence 366 from Patent EP2479285.
JA788165 - Sequence 367 from Patent EP2479285.
JA788662 - Sequence 366 from Patent EP2479286.
JA788663 - Sequence 367 from Patent EP2479286.
JA810996 - Sequence 366 from Patent EP2468890.
JA810997 - Sequence 367 from Patent EP2468890.
JA811494 - Sequence 366 from Patent EP2468891.
JA811495 - Sequence 367 from Patent EP2468891.
JA811992 - Sequence 366 from Patent EP2468893.
JA811993 - Sequence 367 from Patent EP2468893.
JA812490 - Sequence 366 from Patent EP2468894.
JA812491 - Sequence 367 from Patent EP2468894.
JA812988 - Sequence 366 from Patent EP2468895.
JA812989 - Sequence 367 from Patent EP2468895.
JA813486 - Sequence 366 from Patent EP2468896.
JA813487 - Sequence 367 from Patent EP2468896.
JA813984 - Sequence 366 from Patent EP2468897.
JA813985 - Sequence 367 from Patent EP2468897.
JA814482 - Sequence 366 from Patent EP2468898.
JA814483 - Sequence 367 from Patent EP2468898.
JA814980 - Sequence 366 from Patent EP2468899.
JA814981 - Sequence 367 from Patent EP2468899.
JA817223 - Sequence 366 from Patent EP2468892.
JA817224 - Sequence 367 from Patent EP2468892.
JA826035 - Sequence 366 from Patent EP2471956.
JA826036 - Sequence 367 from Patent EP2471956.
JA826533 - Sequence 366 from Patent EP2471958.
JA826534 - Sequence 367 from Patent EP2471958.
JB024820 - Sequence 366 from Patent EP2505668.
JB024821 - Sequence 367 from Patent EP2505668.
JB025318 - Sequence 366 from Patent EP2505669.
JB025319 - Sequence 367 from Patent EP2505669.
JB079705 - Sequence 366 from Patent EP2487252.
JB079706 - Sequence 367 from Patent EP2487252.
JB080203 - Sequence 366 from Patent EP2487253.
JB080204 - Sequence 367 from Patent EP2487253.
JB080701 - Sequence 366 from Patent EP2487254.
JB080702 - Sequence 367 from Patent EP2487254.
JB081199 - Sequence 366 from Patent EP2487255.
JB081200 - Sequence 367 from Patent EP2487255.
JB081697 - Sequence 366 from Patent EP2487256.
JB081698 - Sequence 367 from Patent EP2487256.
JB082195 - Sequence 366 from Patent EP2487257.
JB082196 - Sequence 367 from Patent EP2487257.
JB082693 - Sequence 366 from Patent EP2487258.
JB082694 - Sequence 367 from Patent EP2487258.
JB083191 - Sequence 366 from Patent EP2487259.
JB083192 - Sequence 367 from Patent EP2487259.
JB083689 - Sequence 366 from Patent EP2487260.
JB083690 - Sequence 367 from Patent EP2487260.
JB084187 - Sequence 366 from Patent EP2487261.
JB084188 - Sequence 367 from Patent EP2487261.
JB084685 - Sequence 366 from Patent EP2487262.
JB084686 - Sequence 367 from Patent EP2487262.
JB085183 - Sequence 366 from Patent EP2487263.
JB085184 - Sequence 367 from Patent EP2487263.
JB087861 - Sequence 366 from Patent EP2502630.
JB087862 - Sequence 367 from Patent EP2502630.
JB148065 - Sequence 366 from Patent EP2484782.
JB148066 - Sequence 367 from Patent EP2484782.
JB148563 - Sequence 366 from Patent EP2484783.
JB148564 - Sequence 367 from Patent EP2484783.
JB153288 - Sequence 366 from Patent EP2514433.
JB153289 - Sequence 367 from Patent EP2514433.
JB153786 - Sequence 366 from Patent EP2514434.
JB153787 - Sequence 367 from Patent EP2514434.
JB622375 - Sequence 366 from Patent EP2586454.
JB622376 - Sequence 367 from Patent EP2586454.
JB622873 - Sequence 366 from Patent EP2586455.
JB622874 - Sequence 367 from Patent EP2586455.
JC001936 - Sequence 366 from Patent EP2591794.
JC001937 - Sequence 367 from Patent EP2591794.
JC334093 - Sequence 11 from Patent EP2487240.
LP636956 - Sequence 6 from Patent EP2848702.
DI443401 - KR 1020140074997-A/22: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DI443402 - KR 1020140074997-A/23: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
FW363959 - Oligonucleotides for modulating target RNA activity.
FW371680 - Human-derived nuclear acids for inhibiting HIV protein expression.
FW371723 - Human-derived nuclear acids for inhibiting HIV protein expression.
FW371749 - Human-derived nuclear acids for inhibiting HIV protein expression.
FZ414237 - WO 2011007815-A/127: A method for screening a food which promotes production of milk having immunoregulating effect.
HI965598 - Sequence 883 from Patent WO2010139812.
HI965878 - Sequence 198 from Patent WO2010139811.
HI966744 - Sequence 198 from Patent WO2010139810.
HV335765 - JP 2011093892-A/8: Tumor proliferation suppressor comprising tumor suppressive micro RNA.
HV540980 - WO 2011125469-A/24: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV543892 - JP 2011217617-A/3: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV593806 - JP 2010538610-A/19: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594735 - JP 2010539959-A/116: Micromirs.
HV821765 - JP 2011140513-A/127: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HW060363 - JP 2012527478-A/27: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW248820 - JP 2013514372-A/19: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY.
HW289768 - JP 2013520158-A/11: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW505392 - JP 2014502606-A/294: MELANOMA TREATMENTS.
HW505393 - JP 2014502606-A/295: MELANOMA TREATMENTS.
HW523272 - JP 2014507123-A/57: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW807727 - JP 2014534810-A/22: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW807728 - JP 2014534810-A/23: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW913302 - JP 2015504307-A/62: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ043173 - JP 2015510401-A/263: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043364 - JP 2015510401-A/454: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ073982 - JP 2013535982-A/73: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081799 - JP 2015514392-A/263: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081990 - JP 2015514392-A/454: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082785 - JP 2015513906-A/142: Stem Cell Microparticles.
HZ157292 - JP 2015130862-A/116: Micromirs.
HZ186272 - JP 2015146814-A/21: Oligonucleotides for modulating target RNA activity.
HZ392505 - JP 2015180203-A/11: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ436566 - JP 2015529450-A/142: Stem Cell Microparticles.
HZ479612 - JP 2015535430-A/118: TERMINALLY MODIFIED RNA.
HZ789543 - JP 2016504050-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401636 - Sequence 883 from Patent WO2011080318.
JA402614 - Sequence 883 from Patent WO2011080315.
JA403621 - Sequence 883 from Patent WO2011080316.
JA406252 - Sequence 883 from Patent EP2336353.
JA429778 - Sequence 883 from Patent WO2011095623.
JA660711 - Sequence 165 from Patent WO2011131354.
JA667974 - Sequence 53 from Patent WO2011139911.
JA682599 - Sequence 67 from Patent WO2011149354.
JA781908 - Sequence 19 from Patent EP2513307.
JA791704 - Sequence 106 from Patent WO2012089772.
JA792209 - Sequence 258 from Patent WO2012089753.
JA885427 - Sequence 57 from Patent WO2012083004.
JB022216 - Sequence 58 from Patent WO2013026685.
JB037933 - Sequence 49 from Patent WO2012107841.
JB037935 - Sequence 51 from Patent WO2012107841.
JB049969 - Sequence 56 from Patent WO2013020926.
JB075014 - Sequence 274 from Patent WO2012168448.
JB149052 - Sequence 127 from Patent EP2455486.
JB174975 - Sequence 7 from Patent WO2012101219.
JB233495 - Sequence 27 from Patent EP2437750.
JB406720 - Sequence 46 from Patent WO2012072685.
JB620157 - Sequence 137 from Patent WO2013063544.
JB778683 - Sequence 62 from Patent WO2013078283.
JC171770 - Sequence 142 from Patent WO2013150303.
JC244460 - Sequence 80 from Patent WO2012020308.
JC505991 - Sequence 10 from Patent EP2733219.
JC512275 - Sequence 2528 from Patent WO2014113089.
JC572581 - Sequence 142 from Patent WO2014125276.
JC582269 - Sequence 142 from Patent WO2014125277.
JC737415 - Sequence 10 from Patent WO2014075911.
JE869373 - Sequence 14 from Patent WO2015131115.
JE953965 - Sequence 142 from Patent WO2015052526.
JE955718 - Sequence 142 from Patent WO2015052527.
JE978720 - Sequence 165 from Patent EP2865765.
LF137470 - JP 2016507550-A/142: Method of Producing Microparticles.
LF161151 - JP 2016513950-A/1217: Oligomers with improved off-target profile.
LF162435 - JP 2016513095-A/142: Stem Cell Microparticles and miRNA.
LF404270 - JP 2015509366-A/263: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636233 - JP 2016519076-A/7: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF857570 - JP 2015130879-A/19: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953187 - JP 2016534103-A/142: Stem Cell Microparticles and miRNA.
LG005532 - KR 1020150004822-A/142: STEM CELL MICROPARTICLES.
LG053228 - KR 1020150059168-A/142: STEM CELL MICROPARTICLES.
LG134390 - KR 1020150131312-A/7: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240467 - KR 1020160035087-A/142: STEM CELL MICROPARTICLES AND MIRNA.
LP726504 - Sequence 198 from Patent EP2883966.
LP769606 - Sequence 133 from Patent EP3294910.
LP782001 - Sequence 6 from Patent WO2018055093.
LP818774 - Sequence 198 from Patent EP3296406.
LP835272 - Sequence 70 from Patent WO2017108535.
LP896626 - Sequence 1490 from Patent EP3253886.
LP938716 - Sequence 198 from Patent EP3184651.
LP939579 - Sequence 70 from Patent EP3184646.
LP951523 - Sequence 29 from Patent WO2017157650.
LQ069863 - Sequence 187 from Patent EP2964234.
LQ101344 - Sequence 49 from Patent WO2015101653.
LQ101346 - Sequence 51 from Patent WO2015101653.
LQ276059 - Sequence 49 from Patent WO2016071729.
LQ276061 - Sequence 51 from Patent WO2016071729.
LQ278646 - Sequence 185 from Patent WO2016066288.
LQ441267 - Sequence 274 from Patent EP3029157.
LQ500605 - Sequence 19 from Patent EP3048177.
LQ664820 - Sequence 9 from Patent WO2016150475.
LV470552 - JP 2016534036-A/142: Stem Cell Microparticles and miRNA.
LY404800 - KR 1020160117535-A/105: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY409569 - KR 1020160122850-A/14: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
LY504616 - KR 1020170035932-A/5: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233629 - JP 2017184756-A/21: Oligonucleotides for modulating target RNA activity.
LZ242897 - JP 2017525350-A/5: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA259152 - JP 2017502699-A/49: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA259154 - JP 2017502699-A/51: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA260039 - JP 2017505623-A/105: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA264551 - JP 2017507955-A/14: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
MA353801 - JP 2018075017-A/263: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS834737 - Sequence 883 from Patent EP3112479.
MS901585 - Sequence 58 from Patent EP3156505.
MS904103 - Sequence 19 from Patent EP3138926.
MS944749 - Sequence 5 from Patent EP3177739.
MS946561 - Sequence 7 from Patent WO2017037477.
CQ873632 - Sequence 51 from Patent WO2004076622.
DD413469 - Regulation of Mammalian Cells.
CS266569 - Sequence 261 from Patent WO2005118806.
DL076731 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004381 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261131 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763633 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421723 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304532 - JP 2009531018-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305030 - JP 2009531019-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119239 - JP 2013046612-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367594 - JP 2012228254-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411987 - JP 2014000079-A/261: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589568 - JP 2013121348-A/99: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674333 - JP 2014217381-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067275 - JP 2014012020-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ413372 - JP 2014060993-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427699 - JP 2014217384-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428502 - JP 2014217385-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429305 - JP 2014217386-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430108 - JP 2014217387-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501583 - JP 2016025853-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769365 - JP 2014223080-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058759 - Sequence 261 from Patent EP2298893.
JA059562 - Sequence 261 from Patent EP2298894.
JA073885 - Sequence 261 from Patent EP2281887.
JA105022 - Sequence 261 from Patent EP2302051.
JA106362 - Sequence 261 from Patent EP2302052.
JA107165 - Sequence 261 from Patent EP2302053.
JA107968 - Sequence 261 from Patent EP2302054.
JA108771 - Sequence 261 from Patent EP2302055.
JA109574 - Sequence 261 from Patent EP2302056.
JA192090 - Sequence 261 from Patent EP2290066.
JA192989 - Sequence 261 from Patent EP2290067.
JA193888 - Sequence 261 from Patent EP2290068.
JA194787 - Sequence 261 from Patent EP2290069.
JA195686 - Sequence 261 from Patent EP2290070.
JA196585 - Sequence 261 from Patent EP2290071.
JA197484 - Sequence 261 from Patent EP2290072.
JA198383 - Sequence 261 from Patent EP2290073.
JA199282 - Sequence 261 from Patent EP2290074.
JA200181 - Sequence 261 from Patent EP2290075.
JA201080 - Sequence 261 from Patent EP2290076.
JA218202 - Sequence 261 from Patent EP2281888.
JA226353 - Sequence 261 from Patent EP2292755.
JA229208 - Sequence 261 from Patent EP2292756.
JA257479 - Sequence 261 from Patent EP2284265.
JA278759 - Sequence 261 from Patent EP2281886.
JA284645 - Sequence 261 from Patent EP2281889.
JA292698 - Sequence 261 from Patent EP2287303.
JA317884 - Sequence 261 from Patent EP2314688.
JA374943 - Sequence 261 from Patent EP2322616.
JA525949 - Sequence 99 from Patent EP2369011.
JA526456 - Sequence 99 from Patent EP2369012.
JA526963 - Sequence 99 from Patent EP2369013.
JA535892 - Sequence 99 from Patent EP2371971.
JA787897 - Sequence 99 from Patent EP2479285.
JA788395 - Sequence 99 from Patent EP2479286.
JA810729 - Sequence 99 from Patent EP2468890.
JA811227 - Sequence 99 from Patent EP2468891.
JA811725 - Sequence 99 from Patent EP2468893.
JA812223 - Sequence 99 from Patent EP2468894.
JA812721 - Sequence 99 from Patent EP2468895.
JA813219 - Sequence 99 from Patent EP2468896.
JA813717 - Sequence 99 from Patent EP2468897.
JA814215 - Sequence 99 from Patent EP2468898.
JA814713 - Sequence 99 from Patent EP2468899.
JA816956 - Sequence 99 from Patent EP2468892.
JA825768 - Sequence 99 from Patent EP2471956.
JA826266 - Sequence 99 from Patent EP2471958.
JB024553 - Sequence 99 from Patent EP2505668.
JB025051 - Sequence 99 from Patent EP2505669.
JB079438 - Sequence 99 from Patent EP2487252.
JB079936 - Sequence 99 from Patent EP2487253.
JB080434 - Sequence 99 from Patent EP2487254.
JB080932 - Sequence 99 from Patent EP2487255.
JB081430 - Sequence 99 from Patent EP2487256.
JB081928 - Sequence 99 from Patent EP2487257.
JB082426 - Sequence 99 from Patent EP2487258.
JB082924 - Sequence 99 from Patent EP2487259.
JB083422 - Sequence 99 from Patent EP2487260.
JB083920 - Sequence 99 from Patent EP2487261.
JB084418 - Sequence 99 from Patent EP2487262.
JB084916 - Sequence 99 from Patent EP2487263.
JB087594 - Sequence 99 from Patent EP2502630.
JB147798 - Sequence 99 from Patent EP2484782.
JB148296 - Sequence 99 from Patent EP2484783.
JB153021 - Sequence 99 from Patent EP2514433.
JB153519 - Sequence 99 from Patent EP2514434.
JB622108 - Sequence 99 from Patent EP2586454.
JB622606 - Sequence 99 from Patent EP2586455.
JC001669 - Sequence 99 from Patent EP2591794.
JC221786 - Sequence 261 from Patent EP2471923.
JC268352 - Sequence 261 from Patent EP2471924.
JC340660 - Sequence 261 from Patent EP2471922.
JC469906 - Sequence 261 from Patent EP2471921.
JC990695 - Sequence 261 from Patent EP2808390.
LF714798 - JP 2016165292-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856732 - JP 2015142597-A/261: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
FW363960 - Oligonucleotides for modulating target RNA activity.
HI965597 - Sequence 882 from Patent WO2010139812.
HI966161 - Sequence 481 from Patent WO2010139811.
HI967027 - Sequence 481 from Patent WO2010139810.
HV594736 - JP 2010539959-A/117: Micromirs.
HW505550 - JP 2014502606-A/452: MELANOMA TREATMENTS.
HZ073981 - JP 2013535982-A/72: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157293 - JP 2015130862-A/117: Micromirs.
HZ186273 - JP 2015146814-A/22: Oligonucleotides for modulating target RNA activity.
HZ479613 - JP 2015535430-A/119: TERMINALLY MODIFIED RNA.
HZ789544 - JP 2016504050-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA293244 - Sequence 2 from Patent WO2011014083.
JA401635 - Sequence 882 from Patent WO2011080318.
JA402613 - Sequence 882 from Patent WO2011080315.
JA403620 - Sequence 882 from Patent WO2011080316.
JA406251 - Sequence 882 from Patent EP2336353.
JA427039 - Sequence 372 from Patent WO2011072177.
JA429777 - Sequence 882 from Patent WO2011095623.
JA757932 - Sequence 65 from Patent WO2012010584.
JB022576 - Sequence 418 from Patent WO2013026685.
JB037932 - Sequence 48 from Patent WO2012107841.
JB620156 - Sequence 136 from Patent WO2013063544.
JB770412 - Sequence 39 from Patent EP2604690.
JC008840 - Sequence 39 from Patent WO2013088338.
JC244459 - Sequence 79 from Patent WO2012020308.
JC512276 - Sequence 2529 from Patent WO2014113089.
JC964004 - Sequence 39 from Patent EP2816114.
LF160068 - JP 2016513950-A/134: Oligomers with improved off-target profile.
LP726787 - Sequence 481 from Patent EP2883966.
LP769478 - Sequence 5 from Patent EP3294910.
LP819057 - Sequence 481 from Patent EP3296406.
LP874699 - Sequence 1 from Patent WO2017102838.
LP874929 - Sequence 1 from Patent WO2017102841.
LP938999 - Sequence 481 from Patent EP3184651.
LP951703 - Sequence 209 from Patent WO2017157650.
LQ069864 - Sequence 188 from Patent EP2964234.
LQ101343 - Sequence 48 from Patent WO2015101653.
LQ276058 - Sequence 48 from Patent WO2016071729.
LQ278565 - Sequence 104 from Patent WO2016066288.
LQ425401 - Sequence 2 from Patent EP3037550.
LY404801 - KR 1020160117535-A/106: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504703 - KR 1020170035932-A/92: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233630 - JP 2017184756-A/22: Oligonucleotides for modulating target RNA activity.
LZ242984 - JP 2017525350-A/92: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA259151 - JP 2017502699-A/48: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA260040 - JP 2017505623-A/106: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS834736 - Sequence 882 from Patent EP3112479.
MS901945 - Sequence 418 from Patent EP3156505.
MS944836 - Sequence 92 from Patent EP3177739.
MA643364 - JP 2017113010-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731248 - JP 2017140048-A/118: TERMINALLY MODIFIED RNA.
MA643365 - JP 2017113010-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731249 - JP 2017140048-A/119: TERMINALLY MODIFIED RNA.
MA400946 - JP 2018515097-A/133: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA400818 - JP 2018515097-A/5: Method for Diagnosis and Prognosis of Chronic Heart Failure.
LQ955688 - Sequence 19 from Patent EP2775001.
MA406415 - JP 2018518147-A/45: Detection of Brain Injury.
MA406380 - JP 2018518147-A/10: Detection of Brain Injury.
MP045552 - Sequence 374 from Patent EP3401394.
MP084222 - Sequence 374 from Patent EP3401393.
MP015446 - Sequence 649 from Patent WO2019016252.
MP045441 - Sequence 263 from Patent EP3401394.
MP070414 - Sequence 11 from Patent WO2018231851.
MP084111 - Sequence 263 from Patent EP3401393.
MP084302 - Sequence 454 from Patent EP3401393.
MA800417 - JP 2018183181-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800418 - JP 2018183181-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129242 - Sequence 142 from Patent EP3470073.
MP162165 - Sequence 142 from Patent WO2019069093.
MP197427 - Sequence 2 from Patent EP3532638.
MP264414 - Sequence 1 from Patent EP3502269.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029516
UCSC ID: uc001dbx.3
RefSeq Accession: NR_029516

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029516.1
exon count: 1CDS single in 3' UTR: no RNA size: 75
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 178.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.